Clinical Trial Update: Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing brand versus generic immunosuppression in kidney transplant recipients completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejections

Snippet

Sponsor: University of California, Los Angeles | Conditions: Renal Transplant Rejection | Phase 4 | Status: COMPLETED | Results posted: 2023-04-28